This HTML5 document contains 98 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44565913
rdf:type
wikibase:Item
schema:description
научни чланак artikulong pang-agham scientific article published in December 1990 article scientific ডিসেম্বর ১৯৯০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ wetenschappelijk artikel научна статия artikel ilmiah 1990年学术文章 1990年学术文章 article científic artykuł naukowy мақолаи илмӣ bilimsel makale artigo científico vědecký článek artículo científico publicado en 1990 tudományos cikk 1990年學術文章 artikull shkencor บทความทางวิทยาศาสตร์ scientific article published in December 1990 1990年学术文章 1990年学术文章 articolo scientifico مقالة علمية نشرت في ديسمبر 1990 სამეცნიერო სტატია bài báo khoa học 1990年の論文 научни чланак tieteellinen artikkeli 1990年学术文章 գիտական հոդված հրատարակված 1990 թվականի դեկտեմբերին teaduslik artikkel artigo científico vetenskaplig artikel wissenschaftlicher Artikel 1990 nî lūn-bûn 1990年學術文章 artigo científico 1990年學術文章 наукова стаття, опублікована в грудні 1990 vitskapeleg artikkel 1990년 논문 vedecký článok naučni članak научная статья 1990年學術文章 article scientifique 1990年学术文章 scienca artikolo artículu científicu 1990年學術文章 επιστημονικό άρθρο מאמר מדעי videnskabelig artikel articol științific scientific article published in December 1990 vitenskapelig artikkel
p:P577
wds:Q44565913-064A08C0-2A59-48F0-B20E-8F17945B352B
wdt:P577
1990-12-01T00:00:00Z
p:P2093
wds:Q44565913-0419FF7C-D1F4-4AC7-B4D5-F670B1998FB4 wds:Q44565913-58EA28B5-636C-4419-9BEA-2E4AC51FAF76 wds:Q44565913-38E78693-7680-490B-BAFD-D0C5D2CCD0AE wds:Q44565913-C7927F28-FC29-459D-9753-F1F8034A6AA6 wds:Q44565913-D9521F9C-6EC5-4420-8264-24F98E8C6E77
wdt:P2093
Tunn U Kurth KH Sylvester R Newling DW De Pauw M
rdfs:label
Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group stud Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group stud
skos:prefLabel
Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group stud Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group stud
schema:name
Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group stud Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group stud
p:P50
wds:Q44565913-E6F8843B-DEC4-47F9-B93E-C74166B0423F
wdt:P50
wd:Q17059251
p:P1476
wds:Q44565913-0C04FCB1-5DE2-4488-9B0D-9D88397C9320
wdt:P1476
Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group stud
p:P304
wds:Q44565913-99442B2D-D407-4376-B369-E7C3C84AF13E
wdt:P304
971-975
p:P31
wds:Q44565913-7C7C8558-A525-42FB-9448-D4CBF80CE1A4
wdt:P31
wd:Q13442814
p:P698
wds:Q44565913-92B8C5DD-C785-4A9B-A2E9-1C3EF473B735
wdtn:P698
n12:2126739
wdt:P698
2126739
p:P1433
wds:Q44565913-8D994BA4-0A93-45B3-9511-DC056619E70F
wdt:P1433
wd:Q15708871
p:P433
wds:Q44565913-28F9E2A0-49A4-4A86-B432-4E05EDDF1EA7
p:P478
wds:Q44565913-B21B2CDE-E11E-489C-B7C7-DF9BFDFC844C
wdt:P433
6
wdt:P478
37
p:P356
wds:Q44565913-1B2259FB-BA89-4820-8CD9-EC4CD7338A64
wdtn:P356
n11:0960-0760(90)90452-Q
wdt:P356
10.1016/0960-0760(90)90452-Q